Celgene (CELG) PT Lowered to $102 at Deutsche Bank; 'Ozanimod Not a Disaster'
Tweet Send to a Friend
Deutsche Bank lowered its price target on Celgene (NASDAQ: CELG) to $102.00 (from $110.00) while maintaining a Hold rating, following ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
